BAYRY logo

BAYRY Bayer AG

Other OTC · Drug Manufacturers - General · Healthcare

$15.01
-0.02 (-0.13%)

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specia…

Market Cap: $58.98Bwww.bayer.com

Price

No data yet.

Social Signal Score

42
5d
—
30d
44
12 mentions
—
60d
42
19 mentions
—
90d
41
29 mentions
—
news: 29

Analyst Ratings

3 analysts
Holdconsensus
Strong Buy 0Buy 1Hold 2Sell 0Strong Sell 0

Revenue

$10.05B-14.95%
$8.03B$10.23B$12.43B$14.64B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$1.17
$1.14–$1.19
2 analysts
FY2026
$1.13-3% YoY
$1.12–$1.15
2 analysts
FY2027
$1.22+7% YoY
$1.21–$1.24
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Bill Anderson
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
88,078
Beta
0.83
Country
DE
Piotroski score
5 / 9 (Middling)
Altman Z-score
1.08
www.bayer.com